SCHEMBL20150376

SCHEMBL20150376

Cc1ccc2c3ccc(C)cc3n(-c3ccc(C#N)cc3-c3nc(C)nc(C)n3)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.36
CASP3 P42574 1/20 0.35
GRM2 Q14416 1/20 0.35
USP14 P54578 1/20 0.35
CYP19A1 P11511 1/20 0.34
ALDH1A1 P00352 1/20 0.33
CYP2A6 P11509 1/20 0.33
SETDB1 Q15047 1/20 0.33
CRHR1 P34998 3/20 0.32
CSNK1A1 P48729 1/20 0.32
CSNK1D P48730 1/20 0.32
GSK3B P49841 1/20 0.32
CSNK1G2 P78368 1/20 0.32
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
TDP2 O95551 2/20 0.31
TDO2 P48775 1/20 0.31
IDO2 Q6ZQW0 1/20 0.31
GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20114551 0.94 TDO2 (0.35) ITKCASP3GRM2USP14CYP19A1
SCHEMBL20114573 0.94 CASP3 (0.38) CASP3USP14SETDB1CRHR1GABRG2
SCHEMBL20150391 0.91 CHEK1 (0.36) ITKCASP3GRM2ALDH1A1CYP2A6
SCHEMBL20114637 0.90 ITK (0.38) ITKCASP3GRM2USP14CYP19A1
SCHEMBL20150393 0.89 CYP11B1 (0.37) ITKCASP3GRM2CRHR1
SCHEMBL20150412 0.89 CASP3 (0.35) CASP3GRM2ALDH1A1SETDB1CRHR1
SCHEMBL20156176 0.88 PTGER4 (0.36) CASP3ALDH1A1SETDB1CSNK1A1CSNK1D
SCHEMBL20114587 0.88 CHEK1 (0.40) CASP3GRM2SETDB1
SCHEMBL20150387 0.88 MAPK14 (0.36) GRM2ALDH1A1GABRG2GABRB3GABRA5
SCHEMBL20150394 0.87 CHEK1 (0.34) CASP3GRM2SETDB1CRHR1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 ITK 470/4885CASP3 4223/4885GRM2 1828/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 ITK 470/4885CASP3 4223/4885GRM2 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.